Michael C. Williams
Michael Williams, Co-Head of the firm's Global Citizenship Program, works with clients on a wide range of corporate and transactional matters. Partnering with client legal and business leads, Michael focuses on understanding and helping clients achieve their critical business objectives.
He regularly handles matters for hospitals and academic medical centers as well as healthcare service, biotechnology, pharmaceutical, medical device, and health technology companies. He also works closely with technology-oriented businesses outside the life sciences area, including e-commerce and energy. He frequently deals with complex transactions involving colleagues across specialty areas and geographic regions.
Michael counsels companies at each step, from their initial organization and financing through to maturity. He handles equity financings; buy- and sell-side M&A transactions; strategic collaborations; joint ventures; and complex supply, distribution, and joint development contracts. He also advises on intellectual property protection, technology licensing, executive compensation, tax, and other issues of critical importance to life science and technology companies.
Over his 30-year career at Hogan Lovells, he has worked with a wide range of clients, from closely held and VC-backed private companies to academic medical centers, nonprofit organizations, and public companies. He acts as outside general counsel for certain clients, while other relationships are oriented around particular transactions or financings.
Michael previously chaired the firm's Technology and Recruiting Committees. He serves on several charitable organization boards and is an adjunct faculty member at the University of Virginia School of Law. While in law school, Michael served as editor-in-chief of the Virginia Journal of International Law.
Areas of Focus
Represented a leading academic medical center in the establishment of a regional healthcare alliance joint venture.
Represented a leading university in negotiating a comprehensive management agreement for its affiliated hospital.
Act as outside general counsel to privately-held developer of transfection reagents, stem cell products, and other research tools.
Represented the world's largest tissue bank, in joint development and distribution arrangements, with leading global medical device companies.
Represented two privately held molecular biology research products companies in their respective sales to a global life science company.
Represented a leading energy company in negotiating a joint venture to develop and commercialize a novel power generation technology.
Represented a leading online advertising technology company in VC financings, acquisitions, and other strategic transactions.
Represent a regional Blue Cross and Blue Shield plan in strategic venture investments and collaborations.
Represented a public biotechnology company in sale of its biologics business, and licensing of a novel therapeutic vaccine candidate.
Represented a private-equity backed medical equipment company in acquisition of rights to leading patient support surface product.